Primary Hyperparathyroidism Clinical Trials

10 recruiting

Primary Hyperparathyroidism Trials at a Glance

11 actively recruiting trials for primary hyperparathyroidism are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 4 with 2 trials, with the heaviest enrollment activity in Nantes, Bethesda, and Houston. Lead sponsors running primary hyperparathyroidism studies include National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Nantes University Hospital, and M.D. Anderson Cancer Center.

Browse primary hyperparathyroidism trials by phase

Treatments under study

About Primary Hyperparathyroidism Clinical Trials

Looking for clinical trials for Primary Hyperparathyroidism? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Primary Hyperparathyroidism trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Primary Hyperparathyroidism clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 2Phase 3

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

Primary HyperparathyroidismParathyroid CancerMultiple Endocrine Neoplasias+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)193 enrolled1 locationNCT07444723
Recruiting

Natural History Study of Parathyroid Disorders

Primary HyperparathyroidismParathyroid CancerPseudohypoparathyroidism+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3,000 enrolled1 locationNCT04969926
Recruiting

Parathyroid Tumor Clonal Status

Primary HyperparathyroidismParathyroid Tumor
Washington University School of Medicine839 enrolled1 locationNCT05997810
Recruiting

Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases

GliomaPrimary HyperparathyroidismAmino-Acid Transport Disorder
Tianjin Medical University500 enrolled2 locationsNCT07379463
Recruiting

Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors

Primary HyperparathyroidismParathyroid Gland CarcinomaParathyroid Gland Atypical Adenoma+1 more
M.D. Anderson Cancer Center310 enrolled1 locationNCT03039439
Recruiting

Cohort Primary Hyperparathyroidism

Primary Hyperparathyroidism
Nantes University Hospital403 enrolled1 locationNCT05469087
Recruiting
Not Applicable

18F-choline Positron-emission-tomography - Computed-tomography Compared to Conventional Imaging for Localizing Diseased Parathyroid Glands in Primary Hyperparathyroidism

Primary Hyperparathyroidism
Region Skane88 enrolled1 locationNCT07138820
Recruiting
Phase 4

Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism

Primary Hyperparathyroidism
University of Aarhus140 enrolled1 locationNCT06859580
Recruiting
Phase 4

Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity

Primary HyperparathyroidismHypercalcemia
Joseph Sferra37 enrolled1 locationNCT03935984
Recruiting

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Neuroendocrine NeoplasmParagangliomaPheochromocytoma+23 more
Universidad Nacional Autonoma de Mexico750 enrolled3 locationsNCT06523582
Recruiting

Parathyroid Assessment of Symptoms French Version

Quality of Life in Primary Hyperparathyroidism
Nantes University Hospital750 enrolled1 locationNCT06450431